DK0814791T3 - Aminotetralin-derivat til behandlingen af cardiovaskulære sygdomme - Google Patents

Aminotetralin-derivat til behandlingen af cardiovaskulære sygdomme

Info

Publication number
DK0814791T3
DK0814791T3 DK96907446T DK96907446T DK0814791T3 DK 0814791 T3 DK0814791 T3 DK 0814791T3 DK 96907446 T DK96907446 T DK 96907446T DK 96907446 T DK96907446 T DK 96907446T DK 0814791 T3 DK0814791 T3 DK 0814791T3
Authority
DK
Denmark
Prior art keywords
treatment
cardiovascular diseases
aminotetralin derivative
aminotetralin
derivative
Prior art date
Application number
DK96907446T
Other languages
English (en)
Inventor
Paolo Chiesi
Stefano Bongrani
Roberta Razetti
Maurizio Civelli
Alberto Umile
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Application granted granted Critical
Publication of DK0814791T3 publication Critical patent/DK0814791T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
DK96907446T 1995-03-17 1996-03-13 Aminotetralin-derivat til behandlingen af cardiovaskulære sygdomme DK0814791T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT95MI000532A IT1275935B1 (it) 1995-03-17 1995-03-17 Derivato di aminotetralina per la terapia di malattie cardiovascolari
PCT/EP1996/001060 WO1996029065A2 (en) 1995-03-17 1996-03-13 Aminotetralin derivative for the therapy of cardiovascular diseases

Publications (1)

Publication Number Publication Date
DK0814791T3 true DK0814791T3 (da) 2002-10-07

Family

ID=11370947

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96907446T DK0814791T3 (da) 1995-03-17 1996-03-13 Aminotetralin-derivat til behandlingen af cardiovaskulære sygdomme

Country Status (31)

Country Link
US (2) US6013678A (da)
EP (2) EP0814791B1 (da)
JP (1) JPH11502211A (da)
KR (1) KR100391143B1 (da)
CN (1) CN1112920C (da)
AT (1) ATE218856T1 (da)
AU (1) AU702656B2 (da)
BR (1) BR9607996A (da)
CA (1) CA2215671A1 (da)
CZ (1) CZ288488B6 (da)
DE (1) DE69621786T2 (da)
DK (1) DK0814791T3 (da)
EA (1) EA000937B1 (da)
EE (1) EE04040B1 (da)
ES (1) ES2177769T3 (da)
HK (2) HK1004802A1 (da)
HU (1) HUP9801686A3 (da)
IL (1) IL117518A (da)
IT (1) IT1275935B1 (da)
LT (1) LT4355B (da)
LV (1) LV11882B (da)
MX (1) MX9706971A (da)
NO (1) NO317402B1 (da)
NZ (1) NZ303993A (da)
PL (1) PL183347B1 (da)
PT (1) PT814791E (da)
SI (1) SI9620036B (da)
SK (1) SK282952B6 (da)
TR (1) TR199700963T1 (da)
WO (1) WO1996029065A2 (da)
ZA (1) ZA962073B (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2695157B2 (ja) * 1986-12-29 1997-12-24 松下電器産業株式会社 可変パイプラインプロセッサ
WO2000076544A1 (en) * 1996-03-13 2000-12-21 Chiesi Farmaceutici S.P.A. Aminotetralin derivative for the therapy of cardiovascular diseases
EE200100663A (et) * 1999-06-09 2003-04-15 Chiesi Farmaceutici S.P.A. Aminotetraliini derivaat kardiovaskulaarsete haiguste raviks
EP1331004A3 (en) * 1999-06-09 2003-08-06 CHIESI FARMACEUTICI S.p.A. Aminotetralin Derivative for the Therapy of Cardiovascular Diseases
IT1313583B1 (it) * 1999-07-30 2002-09-09 Chiesi Farma Spa Derivati 2-amminotetralinici per la terapia del glaucoma.
IL152751A0 (en) * 2000-05-12 2003-06-24 Chiesi Farma Spa Optically active 2-aminotetralin derivatives, the processes for the preparation thereof and the therapeutical use of pharmaceutical compositions containing them
SE0101854L (sv) * 2001-05-28 2002-11-29 Bioneris Ab Användning av en förening med en negativt laddad region av grupper för behandling av restenos.
EP1384708A1 (en) * 2002-07-26 2004-01-28 CHIESI FARMACEUTICI S.p.A. Process for the manufacture of form I of nolomirole hydrochloride
US20050101668A1 (en) * 2003-07-24 2005-05-12 Chiesi Farmaceutici S.P.A. Aminotetralin derivatives as a medicament for the treatment and prevention of myocardial ischemic conditions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4134997A (en) * 1977-03-01 1979-01-16 University Of Iowa Research Foundation Effect of an aminotetralin derivative on coronary blood flow in infarcted hearts
SU998342A1 (ru) 1981-12-11 1983-02-23 Предприятие П/Я А-3732 Способ получени синтетического цеолита типа @
IT1218322B (it) * 1982-06-10 1990-04-12 Chiesi Farma Spa Derivati di 1,2,3,4-tetraidronaftalene,procedimento di preparazione e relative composizioni farmaceutiche

Also Published As

Publication number Publication date
PL183347B1 (pl) 2002-06-28
LV11882B (en) 1998-03-20
SK282952B6 (sk) 2003-01-09
LV11882A (lv) 1997-12-20
HUP9801686A3 (en) 1999-10-28
EP0814791A1 (en) 1998-01-07
EA000937B1 (ru) 2000-06-26
NO317402B1 (no) 2004-10-25
CN1112920C (zh) 2003-07-02
CN1181699A (zh) 1998-05-13
NO974267L (no) 1997-11-07
SK125497A3 (en) 1998-02-04
LT4355B (lt) 1998-06-25
IL117518A (en) 2001-05-20
EP1216702A3 (en) 2002-09-04
WO1996029065A2 (en) 1996-09-26
CA2215671A1 (en) 1996-09-26
PL322284A1 (en) 1998-01-19
WO1996029065A3 (en) 1996-11-28
EA199700243A1 (ru) 1998-02-26
SI9620036A (sl) 1998-02-28
NO974267D0 (no) 1997-09-16
HK1048060A1 (zh) 2003-03-21
IT1275935B1 (it) 1997-10-24
PT814791E (pt) 2002-10-31
ZA962073B (en) 1996-11-27
NZ303993A (en) 2000-12-22
TR199700963T1 (xx) 1998-02-21
DE69621786D1 (de) 2002-07-18
EE04040B1 (et) 2003-06-16
AU5107296A (en) 1996-10-08
HK1004802A1 (en) 1998-12-11
EP1216702A2 (en) 2002-06-26
EP0814791B1 (en) 2002-06-12
ATE218856T1 (de) 2002-06-15
ITMI950532A1 (it) 1996-09-17
CZ286697A3 (cs) 1998-03-18
AU702656B2 (en) 1999-02-25
HUP9801686A2 (hu) 1999-06-28
ITMI950532A0 (it) 1995-03-17
SI9620036B (sl) 2002-10-31
EE9700231A (et) 1998-04-15
CZ288488B6 (en) 2001-06-13
ES2177769T3 (es) 2002-12-16
BR9607996A (pt) 1998-06-23
IL117518A0 (en) 1996-07-23
DE69621786T2 (de) 2003-01-02
US6103760A (en) 2000-08-15
KR19980703030A (ko) 1998-09-05
KR100391143B1 (ko) 2003-11-28
LT97147A (en) 1998-02-25
MX9706971A (es) 1997-11-29
US6013678A (en) 2000-01-11
JPH11502211A (ja) 1999-02-23

Similar Documents

Publication Publication Date Title
IL130931A0 (en) Small molecules useful in the treatment of inflammatory disease
KR960702318A (ko) 근육 질병 및 장애의 치료방법
IE791235L (en) Acyl-derivatives of carnitine.
ITTO950104A0 (it) Catetere, particolarmente per il trattamento di aritmie cardiache.
ATE239474T1 (de) Verwendung von levobupivacain
DK0814791T3 (da) Aminotetralin-derivat til behandlingen af cardiovaskulære sygdomme
ATE157871T1 (de) Arzneimittel zur therapeutischen und prophylaktischen behandlung von krankheiten, die durch hyperplasie der glatten muskelzellen bedingt sind
IS5366A (is) Notkun á fankínóni til meðhöndlunar á Alzheimers-sjúkdómi
ITTO950099A0 (it) Catetere, particolarmente per il trattamento di aritmie cardiache.
ATE151774T1 (de) Cyclopentanperhydrophenanthren-17-beta-(3-furyl - 3-derivate und pharmazeutische präparate davon, zur behandlung von kardiovaskulär-erkrankungen
GR3024707T3 (en) Digitoxigenin and dihydrodigitoxigenin 3beta-derivatives and pharmaceutical compositions comprising same for the treatment of cardiovascular disorders
GR3029466T3 (en) 1,5-disubstituted 7a-methylperhydroinden-3a-ol derivatives, active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing them
DK0385422T3 (da) 1,4-Dihydro-5-isopropoxy-2-methyl-4-(2-trifluormethylphenyl)-1,6-naphthyridin-3-carboxylsyre-(-(N-methyl-N-phenylmethylamino)ethyl)ester-fumarat
ITMI950956A0 (it) Uso degli enantiomeri (s) di derivati 1,4-diidropiridinici per il trattamento dell'insufficienza cardiaca
DE500713T1 (de) Derivate des 3,3,5-trimethylcyclohexylesters von 2-methylpropionsaeure, ihr herstellungsverfahren sowie diese enthaltende therapeutische kompositionen.